Toleranzia appoints Torbjörn Sannerstedt as new Chief Financial Officer

15 August - 2022

Toleranzia AB (publ) ("Toleranzia" or the "Company") today announces that the Company has appointed Torbjörn Sannerstedt as its new Chief Financial Officer (CFO). He succeeds Toleranzia's current CFO, David Wahlund, effective today.

Torbjörn Sannerstedt holds a degree in economics and has extensive experience from positions as Chief Financial Officer in companies such as AcadeMedia AB, Navamedic ASA and Halmstad Energi och Miljö AB. He has also been CEO of LMI Selcom AB and Administrative Director of Kinnasand AB. Torbjörn Sannerstedt will carry out his assignment for Toleranzia on a consultancy basis through the company Business Control Partner Norden AB.  
"I am pleased to welcome Torbjörn Sannerstedt as the company's new CFO. His long experience from similar positions in listed companies and good insights into business strategy issues will be very valuable for Toleranzia's continued development. At the same time, I would like to thank David Wahlund for his contribution to the company and wish him all the best for the future", says Charlotte Fribert, CEO, Toleranzia.
For further information, please contact:
Charlotte Fribert – CEO, Toleranzia
Tel: +46 763 19 98 98
About Toleranzia AB (publ)
Toleranzia AB (publ) develops drugs that harness the power of the immune system for the treatment of autoimmune orphan diseases. The drugs, which target the cause of the disease, can cure or significantly alleviate the disease and not, like current treatments, merely reduce the symptoms. They have the potential to be the first long-acting or curative therapies that act specifically on the underlying cause of the autoimmune orphan disease for which they are being developed. Toleranzia's shares are listed on the Nasdaq First North Growth Market and Mangold Fondkommission AB, 08-503 015 50,, is the Company's Certified Adviser.

Subscribe to Toleranzia’s news here